
    
      Primary -

      - To compare the safety profile of a single intravenous administration of FGI-101-1A6 as
      compared with Placebo

      Secondary

        -  To evaluate the pharmacokinetics (PK) of a singel intravenous administration of
           FGI-101-1A6

        -  To evaluate the immunogenicity of FGI-101-1A6
    
  